# Jidong Jia

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jidong-jia/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,224 |
| Field | Liver Disease Diagnosis and Treatment |
| h-index | 63 |
| i10-index | 263 |
| Last Known Institution | National Clinical Research Center for Digestive Diseases |
| OpenAlex ID | https://openalex.org/A5008566878 |
| ORCID iD | https://orcid.org/0000-0002-4673-8890 |
| Works | 597 |

## Researcher papers

- [Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update](https://scholariq.org/papers/asian-pacific-clinical-practice-guidelines-on-the-management-of-hepatitis-b-a/)
- [Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update](https://scholariq.org/papers/asia-pacific-clinical-practice-guidelines-on-the-management-of-hepatocellular/)
- [Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma](https://scholariq.org/papers/asian-pacific-association-for-the-study-of-the-liver-consensus-recommendations/)
- [Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound](https://scholariq.org/papers/serum-hepatitis-b-virus-rna-is-encapsidated-pregenome-rna-that-may-be-associated/)
- [CSH guidelines for the diagnosis and treatment of drug-induced liver injury](https://scholariq.org/papers/csh-guidelines-for-the-diagnosis-and-treatment-of-drug-induced-liver-injury/)
- [Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)](https://scholariq.org/papers/guideline-of-prevention-and-treatment-for-chronic-hepatitis-b-2015-update/)
- [Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update](https://scholariq.org/papers/asian-pacific-association-for-the-study-of-the-liver-apasl-consensus-guidelines/)
- [Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C](https://scholariq.org/papers/shorter-durations-and-lower-doses-of-peginterferon-alfa-2a-are-associated-with/)
- [Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial](https://scholariq.org/papers/telbivudine-versus-lamivudine-in-chinese-patients-with-chronic-hepatitis-b/)

## Researcher topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

## Researcher university

- [National Clinical Research Center for Digestive Diseases](https://scholariq.org/institutions/national-clinical-research-center-for-digestive-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.